EMA blocks revolving door between industry and experts
This article was originally published in SRA
Executive Summary
The European Medicines Agency has updated its conflict of interest rules so that agency experts and committee members who declare intentions to work for a pharmaceutical company will have to cease their involvement in any medicines assessment1.